The positive rate of AR expression in serous carcinomas (23%) was found to be significantly higher than that in non-serous carcinomas (8%) in one of the studies [63], while others showed no significant differences in AR positivity among histological subtypes of carcinoma [61,62,65]. The gene discussed is AR; the disease is serous adenocarcinoma.